3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Gynecologic
1
Conditions
Weight Loss
1
Preleukemia
1
Ovarian Neoplasms
1
Osteochondroma
1
Obesity
1
Non-alcoholic Fatty Liver Disease
1
Nevus, Epithelioid and Spindle Cell
1
Myelodysplastic Syndromes
1
Malnutrition
1
Lung Neoplasms
1
Hematologic Neoplasms
1
Glioblastoma
1
Giant Cell Tumors
1
Gastrointestinal Neoplasms
1
Fibrosis
1
Esophageal Squamous Cell Carcinoma
1
Endometrial Neoplasms
1
Endometrial Hyperplasia
1
Carcinoma, Merkel Cell
1
Carcinoma, Lobular
1
Carcinoma in Situ
1
Barrett Esophagus
1
Interventions
Carboplatin
156
Paclitaxel
154
Bevacizumab
96
Cyclophosphamide
61
Gemcitabine
46
olaparib
45
Cisplatin
45
Topotecan
44
niraparib
40
liposomal doxorubicin
40
pembrolizumab
38
Surveys and Questionnaires
33
Filgrastim
31
Hyperthermic Intraperitoneal Chemotherapy
29
Docetaxel
27
Taxes
25
Blood Specimen Collection
24
fludarabine
23
Drug Therapy
23
Cytoreduction Surgical Procedures
23
Peripheral Blood Stem Cell Transplantation
21
Etoposide
21
Doxorubicin
21
Magnetic Resonance Spectroscopy
20
durvalumab
17
Specimen Handling
17
Albumin-Bound Paclitaxel
17
Immunoglobulin G
15
Disulfides
15
Letrozole
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Ovarian Neoplasms
×
Sampling Studies
×
Clear all
NCT03027479
2025-12-22
METERMUS-IMC
University Hospital, Tours
Phase NA
Completed
70 enrolled